1. Home
  2. NNVC vs NSRX Comparison

NNVC vs NSRX Comparison

Compare NNVC & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NNVC

NanoViricides Inc.

HOLD

Current Price

$1.52

Market Cap

37.9M

Sector

Health Care

ML Signal

HOLD

Logo Nasus Pharma Ltd. Ordinary Shares

NSRX

Nasus Pharma Ltd. Ordinary Shares

HOLD

Current Price

$3.02

Market Cap

38.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNVC
NSRX
Founded
2005
2019
Country
United States
Israel
Employees
N/A
7
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.9M
38.9M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
NNVC
NSRX
Price
$1.52
$3.02
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$19.67
AVG Volume (30 Days)
375.6K
11.0K
Earning Date
05-15-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
10.00
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.85
$1.98
52 Week High
$2.23
$9.99

Technical Indicators

Market Signals
Indicator
NNVC
NSRX
Relative Strength Index (RSI) 48.51 50.48
Support Level $1.18 $2.78
Resistance Level $1.63 $3.60
Average True Range (ATR) 0.15 0.21
MACD -0.01 -0.01
Stochastic Oscillator 17.22 44.60

Price Performance

Historical Comparison
NNVC
NSRX

About NNVC NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: